...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens.
【24h】

Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens.

机译:评估API An-IDENT和RapID ANA II系统以从临床标本中鉴定放线菌物种。

获取原文
           

摘要

We compared the accuracy of the An-IDENT system (bioMerieux Vitek, Inc., Hazelwood, Mo.) and the RapID ANA II system (Innovative Diagnostic Systems, Norcross, Ga.) with that of conventional biochemical tests for the identification of 85 strains of Actinomyces species. In our hands, the overall accuracy of the An-IDENT was 59% and that of the RapID ANA II was 24%. The error rate for the An-IDENT was 18% and that for the RapID ANA II was 38%. The results of this study suggest that although the An-IDENT was more accurate than the RapID ANA II (P < 0.005), neither system, in our hands, was able to identify Actinomyces species with an acceptable degree of accuracy. It is recommended that suspected Actinomyces isolates be identified by conventional testing.
机译:我们将An-IDENT系统(bioMerieux Vitek,Inc.,Hazelwood,密苏里州)和RapID ANA II系统(Innovative Diagnostic Systems,诺克罗斯,乔治亚州)的准确性与常规生化测试的准确性进行了比较,以鉴定85个菌株放线菌物种。在我们手中,An-IDENT的整体准确性为59%,RapID ANA II的整体准确性为24%。 An-IDENT的错误率为18%,RapID ANA II的错误率为38%。这项研究的结果表明,尽管An-IDENT比RapID ANA II更准确(P <0.005),但我们手中的两个系统都不能以可接受的准确度鉴定放线菌。建议通过常规检测鉴定可疑放线菌菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号